MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Integer Holdings Corporation Operating Expenses 2011-2025 | ITGR
Annual Operating Expenses Integer Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 251 M | 247 M | 233 M | 201 M | 165 M | 189 M | 173 M | 228 M | 222 M | 156 M | 158 M | - | 176 M | 119 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 251 M | 119 M | 194 M |
Quarterly Operating Expenses Integer Holdings Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.7 M | 69.8 M | 70.8 M | - | 58.6 M | 62.9 M | 69.6 M | - | 56.2 M | 64.2 M | 62.5 M | - | 57.5 M | 60.2 M | 59 M | - | 48.8 M | 49.4 M | 49.9 M | - | 18.2 M | 48.7 M | 52.6 M | - | 46.9 M | 47.6 M | 49.4 M | - | 50.5 M | 54.4 M | 53.5 M | - | 53.4 M | 53.1 M | 64.7 M | - | 61 M | 66.8 M | 80.3 M | - | 50.5 M | 44.9 M | 43 M | - | 41.9 M | 38.9 M | 35.1 M | - | 38.9 M | 40.2 M | 34.4 M | - | 48.8 M | 40.8 M | 35.7 M | - | 29 M | 28.3 M | 29.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 80.3 M | 18.2 M | 50.9 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 96.13 | 0.04 % | $ 141 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.6 | - | $ 125 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 301.75 | 0.24 % | $ 8.51 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 48.12 | 0.21 % | $ 7.17 K | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 124.81 | 0.22 % | $ 217 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 2.97 | 4.58 % | $ 111 M |  France |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.14 | 3.64 % | $ 18.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 9.54 | - | $ 685 M | Israel |
 |
InMode Ltd.
INMD
|
136 M | $ 14.47 | 0.7 % | $ 1.15 B | Israel |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 97.06 | 0.48 % | $ 1.23 B | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 157.84 | 0.69 % | $ 11.8 B | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.86 | 0.43 % | $ 88.4 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 63.08 | -0.27 % | $ 3.42 B |  Britain |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 14.49 | 0.84 % | $ 392 M | USA |
|
LENSAR
LNSR
|
32.6 M | $ 12.01 | -0.08 % | $ 138 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 14.53 | 0.07 % | $ 95.2 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 32.64 | -0.61 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 40.17 | 1.34 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 17.41 | 0.75 % | $ 402 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 88.43 | -0.38 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 12.66 | 0.56 % | $ 975 M | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.49 | -6.39 % | $ 3.89 M | USA |
 |
Establishment Labs Holdings
ESTA
|
160 M | $ 75.65 | -0.63 % | $ 2.13 B |  Costa-rica |
 |
Electromed
ELMD
|
40.3 M | $ 28.73 | 5.05 % | $ 243 M | USA |